Lee Pharmaceuticals, Inc. filed its 1-K on Apr 27, 2023 for the period ending Dec 31, 2022. In this report its auditor, Olayinka Oyebola & Co, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0006 USD | -14.29% | -33.33% | -97.67% |
1st Jan change | Capi. | |
---|---|---|
-97.67% | 368K | |
+35.50% | 300B | |
+18.88% | 82.12B | |
+5.58% | 71.52B | |
+7.42% | 70.32B | |
+19.41% | 53.62B | |
+27.62% | 52.28B | |
+4.92% | 51.06B | |
+28.00% | 43.93B | |
+22.60% | 39.41B |
- Stock Market
- Equities
- RONN Stock
- News RONN Inc.
- Lee Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt